Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024 Investing 1 Min Read

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com